Point72 Asset Management Reports 3.3% Stake in Century Therapeutics (IPSC)

Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, filed a Schedule 13G/A on May 15, 2026, disclosing a 3.3% ownership stake in Century Therapeutics, Inc. (IPSC). The reporting persons collectively hold 5,964,678 shares of common stock as of the event date on March 31, 2026. This represents an increase from a previously reported 0.0% position, indicating a new significant holding by the firm. Point72 Asset Management maintains investment and voting power over these shares through an investment fund it manages, while Point72 Capital Advisors serves as the general partner and Steven A. Cohen maintains overall control. The filing is an amendment (Amendment No. 2) and signifies that the securities were acquired in the ordinary course of business without the intent to change or influence the control of the issuer. The principal business office for the reporting entities is located in Stamford, Connecticut.